Your browser doesn't support javascript.
loading
Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model.
Karampitsakos, Theodoros; Kalogeropoulou, Christina; Tzilas, Vasilios; Papaioannou, Ourania; Kazantzi, Alexandra; Koukaki, Evangelia; Katsaras, Matthaios; Bouros, Evangelos; Tsiri, Panagiota; Tsirikos, Georgios; Zarkadi, Eirini; Ntoulias, Nikolaos; Sotiropoulou, Vasilina; Efthymiou, Panagiotis; Chrysikos, Serafeim; Malakounidou, Elli; Sampsonas, Fotios; Bouros, Demosthenes; Tzouvelekis, Argyrios.
Afiliação
  • Karampitsakos T; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece, thodoriskarampitsakos@gmail.com.
  • Kalogeropoulou C; Department of Radiology, University Hospital of Patras, Patras, Greece.
  • Tzilas V; First Academic Department of Pneumonology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Papaioannou O; Athens Medical Center, Athens, Greece.
  • Kazantzi A; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Koukaki E; Department of Radiology, University Hospital of Patras, Patras, Greece.
  • Katsaras M; First Academic Department of Pneumonology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Bouros E; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Tsiri P; First Academic Department of Pneumonology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsirikos G; Athens Medical Center, Athens, Greece.
  • Zarkadi E; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Ntoulias N; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Sotiropoulou V; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Efthymiou P; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Chrysikos S; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Malakounidou E; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Sampsonas F; 5th Department of Pneumonology, Hospital for Thoracic Diseases "SOTIRIA,", Athens, Greece.
  • Bouros D; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
  • Tzouvelekis A; Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece.
Respiration ; 101(3): 262-271, 2022.
Article em En | MEDLINE | ID: mdl-34592744
ABSTRACT

INTRODUCTION:

Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is amenable to avoid potential side effects.

METHODS:

Functional indices and high-resolution computed tomography (HRCT) patterns of patients with non-IPF ILDs receiving mycophenolate mofetil (MMF) with a minimum follow-up of 1 year were analyzed. Two independent radiologists and a machine learning software system (Imbio 1.4.2.) evaluated HRCT patterns.

RESULTS:

Fifty-five (n = 55) patients were included in the analysis (male 30 [55%], median age 65.0 [95% CI 59.7-70.0], mean forced vital capacity %predicted [FVC %pred.] ± standard deviation [SD] 69.4 ± 18.3, mean diffusing capacity of lung for carbon monoxide %pred. ± SD 40.8 ± 14.3, hypersensitivity pneumonitis 26, connective tissue disease-ILDs [CTD-ILDs] 22, other ILDs 7). There was no significant difference in mean FVC %pred. post-6 months (1.59 ± 2.04) and 1 year (-0.39 ± 2.49) of treatment compared to baseline. Radiographic evaluation showed no significant difference between baseline and post-1 year %ground glass opacities (20.0 [95% CI 14.4-30.0] vs. 20.0 [95% CI 14.4-25.6]) and %reticulation (5.0 [95% CI 2.0-15.6] vs. 7.5 [95% CI 2.0-17.5]). A similar performance between expert radiologists and Imbio software analysis was observed in assessing ground glass opacities (intraclass correlation coefficient [ICC] = 0.73) and reticulation (ICC = 0.88). Fourteen patients (25.5%) reported at least one side effect and 8 patients (14.5%) switched to antifibrotics due to disease progression.

CONCLUSION:

Our data suggest that MMF is a safe and effective steroid-sparing agent leading to disease stabilization in a proportion of patients with non-IPF ILDs. Machine learning software systems may exhibit similar performance to specialist radiologists and represent fruitful diagnostic and prognostic tools.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Fibrose Pulmonar Idiopática Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respiration Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Fibrose Pulmonar Idiopática Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respiration Ano de publicação: 2022 Tipo de documento: Article